Textual Amendments
F1Sch. 4A inserted (30.8.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 9) Regulations 2021 (S.I. 2021/966), regs. 1(2), 14
Textual Amendments
F2Sch. 4A Pt. 1 inserted (9.10.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 14) Regulations 2021 (S.I. 2021/1130), regs. 1(2), 18(3) (with reg. 23)
3.—(1) This paragraph applies to a person (“P”) who—
(a)is not a person to whom paragraph 2 of this Schedule applies;
(b)is a person who has been registered to attend the COP with the secretariat of the United Nations Framework Convention on Climate Change, and has confirmation of their registration from the secretariat;
(c)meets the conditions in regulation 3B (eligible travellers) as that regulation applies in relation to P with the modifications made by this paragraph.
(2) Regulation 3A (interpretation of Part) applies in relation to P as if, for the definition of “authorised vaccine”, there were substituted—
““authorised vaccine” means a medicinal product for vaccination against coronavirus authorised—
following evaluation by the regulator for a country or territory, or
otherwise by the government of a country or territory, or pursuant to its authority;”.
(3) Regulation 3B applies in relation to P as if in paragraph (1)(b) the reference to regulations 3C to 3H were a reference to 3C to 3G.
(4) Regulation 3C applies in relation to P as if—
(a)paragraph (1)(b) to (e) were omitted;
(b)for paragraph (2)(a) there were substituted—
“(a)P has completed a course of doses of an authorised vaccine if P has received the complete course of doses of the authorised vaccine as specified in the manufacturer’s guidance for that vaccine;”;
(c)paragraph (3) were omitted.
(5) These Regulations apply in relation to P as if for regulations 3D and 3E there were substituted—
“3D. P meets the requirements of this regulation if P has participated, or is participating in a clinical trial regulated by the relevant regulator in the country or territory where the trial is carried out, of a vaccine for vaccination against coronavirus and has declared on the Passenger Locator Form that P meets the COVID-19 vaccine eligibility criteria.”.
(6) Regulation 3G applies in relation to P as if paragraph (b) were omitted.
(7) These Regulations apply in relation to P as if regulation and 3H and 3I were omitted.
(8) Regulation 3J applies in relation to P as if—
(a)paragraphs (2) to (5) were omitted;
(b)the reference in each of paragraphs (6) and (7) to “the day 2 test” were a reference to “a day 2 test”.
(9) These Regulations apply in relation to P as if paragraph 10(3) to (5) of Schedule 8 were omitted.
[F3(9A) Regulation 4 (requirement to possess notification of negative test result) applies in relation to P as if paragraph (6)(d) were omitted.]
(10) These Regulations apply in relation to P as if, other than regulation 4, Part 2 of these Regulations does not apply to P.]]
Textual Amendments